OCD
OCD treatment from Dr. Gabby Farkas, MD PhD — specialist dosing, augmentation, and ERP coordination.
Obsessive-compulsive disorder is widely misunderstood — both by patients who experience it and by clinicians who treat it. The NIMH — OCD describes OCD as a chronic but highly treatable condition, with response rates that improve substantially when treatment is delivered at the right intensity and combined correctly with therapy. For patients dealing with erp therapy ocd medication, the specifics of dosing, duration, and augmentation matter more than they do in most other conditions.
Key Takeaways

OCD is defined by obsessions (intrusive, unwanted thoughts that cause distress) and compulsions (repetitive behaviors or mental acts done to reduce the distress). Per NIMH — OCD, OCD affects roughly 1–2% of adults, with onset typically in childhood, adolescence, or early adulthood.
International OCD Foundation resources describe the broad spectrum of OCD presentations — contamination, harm, symmetry, religious/scrupulosity, sexual-orientation OCD, relationship OCD, and many others. Recognition matters because OCD is often missed when the obsessions are not the stereotypical contamination type.
OCD treatment differs from depression treatment in important ways:
Combined medication and ERP outperforms either alone for most patients. OCD care covers the full framework.
Specialist psychiatric care for OCD is particularly useful when:
The International OCD Foundation maintains directories of OCD-specialty providers, and coordination between medication management and ERP therapy improves outcomes.
Not all intrusive thoughts indicate OCD. Per NIMH — OCD, intrusive thoughts are universal — research suggests over 90% of the general population experiences them. What distinguishes OCD is:
This distinction is particularly important in perinatal OCD, where intrusive thoughts about harm to the baby cause profound suffering — and where the response pattern (avoidance, hypervigilance, reassurance-seeking) is the opposite of an actual risk indicator.
Understanding erp therapy ocd medication requires more than a definition — it requires the framework a thoughtful clinician brings to the evaluation. The NIMH — OCD and International OCD Foundation publish resources that catalogue the evidence base, but the practical work involves matching evidence to the patient.
This article aims to give patients and families the framework an MD/PhD-trained psychiatrist would explain in clinic — clinically substantive, sourced where it matters, and honest about where uncertainty remains.
OCD typically requires SSRI doses above standard depression dosing, often at the upper end of the FDA range per APA Practice Guidelines guidance. Subtherapeutic dosing is one of the most common reasons OCD treatment looks like it "failed."
Medication helps many patients meaningfully, but combined medication and ERP outperform either alone. ERP is the evidence-based gold-standard therapy for OCD.
Almost never. OCD-style intrusive thoughts are ego-dystonic — they horrify the person experiencing them. The compulsive avoidance and checking pattern is the opposite of actual risk.
The Problem
Many patients with erp therapy ocd medication receive treatment that is not fully optimized — subtherapeutic dosing, premature switching, or missing comorbidity recognition.
The Approach
Diagnostic precision, evidence-based prescribing, measurement-based follow-up, and willingness to deprescribe.
The Outcome
Treatment that achieves and maintains remission — not just partial response that erodes quality of life.
MD/PhD-trained psychiatric care via telehealth across South Carolina, New York, and Virginia.
Educational content only. This article does not constitute medical advice and does not establish a doctor-patient relationship. If you are experiencing a psychiatric emergency, call 911 or 988, or go to your nearest emergency room. Treatment decisions should be made in collaboration with a qualified clinician familiar with your specific circumstances.
MD/PhD-level psychiatric care. Most new patients seen within 2–4 weeks.
Telehealth across South Carolina, New York, and Virginia. In-network with Aetna and Cigna.
Fill out the form below and we'll get back to you within 24 hours.
We've received your request and will be in touch within 24 hours.